Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02578628 · ClinicalTrials.gov registry record · NA
Discontinuation of Automated Engagement Support
A NA study, sponsored by University of Vermont.
- Terminated
- Registry status
- NA
- Development phase
- 488
- Enrollment target
NCT02578628: Clinical Trial NA study, sponsored by University of Vermont.
NCT02578628 is a NA study that was terminated before completion, run by University of Vermont. The registered enrollment target is 488 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02578628, a NA study, was terminated before completion, sponsored by University of Vermont.
- TERMINATED
- Registry status
- NA
- Development phase
- 488 participants
- Enrollment target
Study Summary
The Chronic Kidney Disease Engagement System is currently in place for 1700 adults receiving care from Empire Physicians Medical Group (EPMG), an Independent Practice Association located in Palm Desert, California. The system monitors routine clinical laboratory test results and send messages to patients and providers when action is indicated, such as when tests are overdue or results require extra clinical attention. This study will assess what happens to laboratory results, utilization of laboratory tests, and costs of care when ther system is discontinued.
Primary Outcome
Total and breakdown by categories
Interventions
- OTHER Patient Engagement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 488 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-12-31 |
| Phase | NA |
Why NCT02578628 stopped before completion
NCT02578628 is an interventional study that assigns participants to a tested intervention. The registered 488 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 1 intervention - of which Patient Engagement is the first listed.
NCT02578628 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02578628 about?
NCT02578628 is a clinical study titled "Discontinuation of Automated Engagement Support". The Chronic Kidney Disease Engagement System is currently in place for 1700 adults receiving care from Empire Physicians Medical Group (EPMG), an Independent Practice Association located in Palm Desert, California. The system monitors routine clinical laboratory test results and send messages to pat...
What is the current status of trial NCT02578628?
This trial is currently terminated. It is a NA study. The enrollment target is 488 participants. The study started on 2015-10. Estimated completion is 2017-12-31.
What interventions are being tested in trial NCT02578628?
The interventions under investigation include: Patient Engagement (OTHER).
Who is sponsoring clinical trial NCT02578628?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02578628's enrollment target sits among peer trials
488 215th of 2000 higher than 1,785 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05154669 · 488 participants · Phase 3
Integrating Financial Coaching and Smoking Cessation Coaching
- NCT06532877 · 488 participants · NA
Telephone Support in Advanced Gastrointestinal Cancer
- NCT06602479 · 488 participants · Phase 2
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- NCT06794983 · 488 participants · NA
Calls and Coordination for Transitions of Care at Re-entry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia